Wei Cao, based in Shanghai, Shanghai, China, is currently a CEO at Gracell, Member of AstraZeneca Group, bringing experience from previous roles at Gracell Biotechnologies, 6 Dimensions Capital and Cellular Biomedicine Group Inc.. Wei Cao holds a Research fellow in Immunopharmacology @ Stanford University School of Medicine. With a robust skill set that includes Immunology, Biotechnology, Cancer, Stem Cells, R&D and more, Wei Cao contributes valuable insights to the industry. Wei Cao has 1 email on RocketReach.